{"raw_mentions": "The \u03b13 subunit binding affinity (Ki) of the compounds of the invention is ideally 10 nM or less, preferably 2 nM or less, and more preferably 1 nM or less. \nThe compounds according to the present invention will ideally elicit at least a 40%, preferably at least a 50%, and more preferably at least a 60%, potentiation of the GABA EC20 response in stably transfected recombinant cell lines expressing the \u03b13 subunit of the human GABAA receptor. \nThe compounds of the invention will ideally elicit at most a 30%, preferably at most a 20%, and more preferably at most a 10%, potentiation of the GABA EC20 response in stably transfected recombinant cell lines expressing the \u03b1l subunit of the human GABAA receptor."}
{"final_json": [{"molecule_name": "compounds of the invention", "protein_target_name": "\u03b13 subunit of the human GABAA receptor", "binding_metric": "Ki", "value": "10 nM", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "compounds of the invention", "protein_target_name": "\u03b13 subunit of the human GABAA receptor", "binding_metric": "Ki", "value": "2 nM", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "compounds of the invention", "protein_target_name": "\u03b13 subunit of the human GABAA receptor", "binding_metric": "Ki", "value": "1 nM", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "compounds of the invention", "protein_target_name": "\u03b13 subunit of the human GABAA receptor", "binding_metric": "EC20", "value": "40%", "unit": "%", "is_logarithmic": false}, {"molecule_name": "compounds of the invention", "protein_target_name": "\u03b13 subunit of the human GABAA receptor", "binding_metric": "EC20", "value": "50%", "unit": "%", "is_logarithmic": false}, {"molecule_name": "compounds of the invention", "protein_target_name": "\u03b13 subunit of the human GABAA receptor", "binding_metric": "EC20", "value": "60%", "unit": "%", "is_logarithmic": false}, {"molecule_name": "compounds of the invention", "protein_target_name": "\u03b1l subunit of the human GABAA receptor", "binding_metric": "EC20", "value": "30%", "unit": "%", "is_logarithmic": false}, {"molecule_name": "compounds of the invention", "protein_target_name": "\u03b1l subunit of the human GABAA receptor", "binding_metric": "EC20", "value": "20%", "unit": "%", "is_logarithmic": false}, {"molecule_name": "compounds of the invention", "protein_target_name": "\u03b1l subunit of the human GABAA receptor", "binding_metric": "EC20", "value": "10%", "unit": "%", "is_logarithmic": false}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* The cells are scraped and placed in a 50 ml centrifuge tube is not relevant, however:  \u2022 50 \u03bcl of [<sup>3</sup>H]-flumazenil (final concentration for \u03b1l\u03b23\u03b32: 1.8 nM; for \u03b12\u03b23\u03b32: 1.8 nM; for \u03b13\u03b23\u03b32: 1.0 nM).\n* The compounds of the accompanying Examples were tested in the above assay, and all were found to possess a Ki value for displacement of [<sup>3</sup>H]-flumazenil from the \u03b12 and/or \u03b13 subunit of the human GABAA receptor of 100 nM or less."}
{"final_json": [{"molecule_name": "[<sup>3</sup>H]-flumazenil", "protein_target_name": "\u03b1l\u03b23\u03b32", "binding_metric": null, "value": "1.8", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "[<sup>3</sup>H]-flumazenil", "protein_target_name": "\u03b12\u03b23\u03b32", "binding_metric": null, "value": "1.8", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "[<sup>3</sup>H]-flumazenil", "protein_target_name": "\u03b13\u03b23\u03b32", "binding_metric": null, "value": "1.0", "unit": "nM", "is_logarithmic": false}, {"molecule_name": null, "protein_target_name": "\u03b12 and/or \u03b13 subunit of the human GABAA receptor", "binding_metric": "Ki", "value": "<=100", "unit": "nM", "is_logarithmic": false}]}
